首页
生知快讯
技术天地
技术新突破
期刊应用实例
技术发展方向
文献视角
Biomarker研究
细胞生物学
基因组生物学
分子生物学
行业速报
行业新资讯
上下游动态
产业新趋势
文献园地
文献库
期刊库
文献重点解析
登录/注册
首页
>
期刊库
>
期刊详情
Mol Cancer Ther
收藏
期刊全称
Mol Cancer Ther
注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎
向我反馈
。
期刊相关文献 (98)
Broadening the Therapeutic Window of ADCs Using Site-Specific Bioconjugation Showcased by an MMAE-Containing Peptide Linker in a CD79b-Targeting ADC
利用位点特异性生物偶联拓宽抗体药物偶联物的治疗窗口——以靶向CD79b的含MMAE肽连接子为例
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-0983
Philipp Probst # ,Isabella Attinger-Toller # ,Romain Bertrand ,Ramona Stark ,Roger Santimaria ,Bernd Schlereth ,Dragan Grabulovski ,Philipp René Spycher
Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion-Defined Rhabdomyosarcoma
将全基因组测序分析与独特的患者来源模型相结合,揭示了TFCP2融合定义的横纹肌肉瘤中具有临床意义的药物靶点
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-0704
Patrick Bergsma # ,Sean Porazinski # ,Aji Istadi # ,Diego Chacon-Fajardo ,Yasir Mahmood ,Silvia Lombardi ,Diana Schuhmacher ,Henry Barraclough-Franks ,Dario Strbenac ,Claude V Dennis ,Payam Faizi-Sobbi ,Emer Cahill ,Vivek A Bhadri ,Jeneffer De Almeida Silva ,Trina Lum ,James Wykes ,Timothy Manzie ,Carsten E Palme ,Jean Y H Yang ,Jonathan R Clark ,Ruta Gupta ,Marina Pajic
Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity Against Integrin αvβ3+ Cancers
巨噬细胞结合IgG4抗体触发针对整合素αvβ3+癌细胞的细胞毒性
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-25-0300
Joshua P Reddy ,Ziqi Yu ,Ryan M Shepard ,Tami Von Schalscha ,Rebecca A Clague ,Beatriz P Peixoto ,Stephen J McCormack ,Mark W Onaitis ,Sara M Weis ,David A Cheresh ,Hiromi I Wettersten
Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
通过抑制PI3K-mTOR通路来减弱EZH2的活性,从而克服三阴性乳腺癌的转移和免疫治疗耐药性
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-0693
Michelle Melino # ,Wen Juan Tu # ,Helle Bielefeldt-Ohmann ,Martina Proctor ,Taniya Ahuja ,John Vandermeide ,Amanda L Bain ,Gahyathiri Nallan ,Sal Lee Goh ,Thiru Prasanna ,Jane E Dahlstrom ,Mariska Miranda ,Ramesh Kumar Chaudhary ,Aravind Anandam ,Sumit Chaudhary ,Jonathan T Seal ,Debottam Sinha ,Shaoqian Zhang ,Tam Hong Nguyen ,Sriganesh Srihari ,Gunter Hartel ,Amy Ives ,Laeeq Malik ,Desmond Yip ,Michelle Nottage ,Melissa Eastgate ,Sudha Rao
Preclinical Characterization of XB010: A Novel Antibody-Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4
XB010的临床前表征:一种靶向肿瘤相关抗原5T4的新型抗体-药物偶联物,用于治疗实体瘤
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-1014
Brian A Mendelsohn ,Kathleen R Gogas ,Jeffrey N Higaki ,Willy A Solis ,Inna Vainshtein ,Jackie Cheng ,Minjong Park ,Marlene A Hennessy ,Christine M Janson ,Yutaka Matsuda ,Robyn M Barfield ,Penelope M Drake ,Stepan Chuprakov ,Colin L Hickle ,Tom Linz ,Maxine Bauzon ,Dominick Y Yeo ,Fangjiu Zhang ,Ayodele O Ogunkoya ,Seema Kantak
Cancer Cell Permeability Induced by Tumor Treating Fields (TTFields) as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug Resistance
利用肿瘤电场(TTFields)诱导癌细胞通透性,作为一种提高化疗药物吸收和克服多药耐药性的物理方法
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-25-0019
Bella Koltun ,Tali Voloshin ,Cfir David ,Tal Kan ,Yiftah Barsheshet ,Alexandra Volodin ,Shay Cahal ,Catherine Tempel-Brami ,Mai Shai ,Sara Jacobovitch ,David Roash-Lancry ,Boris Brant ,Noa Kaynan ,Lilach Koren ,Anat Klein-Goldberg ,Efrat Zemer Tov ,Rom Paz ,Adi Haber ,Moshe Giladi ,Uri Weinberg ,Yoram Palti
Preclinical Pharmacokinetic, Pharmacodynamic, and Safety Profile of OBI-992: A Novel TROP2-Targeted Antibody-Drug Conjugate
OBI-992 的临床前药代动力学、药效学和安全性概况:一种新型的靶向 TROP2 的抗体-药物偶联物
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-1176
Chi-Sheng Shia ,Shih-Ni Wen ,Ren-Yu Hsu ,Jyy-Shiuan Tu ,Hui-Wen Chang ,Hao-Cheng Weng ,Jhih-Jie Yang ,Ming-Feng Chiang ,Yu-Hsuan Tsao ,Chi-Huan Lu ,Yu-Hung Chen ,Yi-Chen Wu ,Ya-Chi Chen ,Wan-Fen Li ,Teng-Yi Huang ,Ming-Tain Lai
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control
肿瘤整合素靶向葡萄糖氧化酶促进ROS介导的细胞死亡,可与干扰素α疗法联合用于肿瘤控制
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-0163
Jordan A Stinson ,Allison Sheen ,Brianna M Lax ,Grace N Yang ,Lauren Duhamel ,Luciano Santollani ,Elizabeth Fink ,Joseph R Palmeri ,Karl Dane Wittrup
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
一种新型B7-H4xCD3双特异性T细胞衔接器(PF-07260437)与乳腺癌标准疗法和免疫检查点疗法具有协同作用
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-0379
Keith Abayasiriwardana # ,Lei Wu # ,Hanane Laklai # ,Malgorzata Nocula-Lugowska ,Lioudmila Tchistiakova ,Jatin Narula ,Amy Jackson-Fisher ,Jonathon Golas ,My-Hanh Lam ,Veronika Grinstein ,Jung Wook Kang ,Jessica C Kearney ,Christine Hosselet ,Erik Upeslacis ,LuAnna Lemon ,Yun Zhang ,Changhua Ji ,Bernard S Buetow ,Martin B Finkelstein ,Netonia Marshall ,Stephanie Bisulco ,Edward Rosfjord ,Divya Mathur ,Jennifer Athanacio ,Ashley Thomas ,Alexander Trageser ,Diane Fernandez ,Ziyue Karen Jiang ,Sripad Ram ,Edward Cabral ,Lisa Manzuk ,Kevin Maresca ,Anand Giddabasappa ,Clare Lees ,Andrea T Hooper ,Puja Sapra ,Sudhakar Chintharlapalli
Novel Amanitin-Based Antibody-Drug Conjugates Targeting TROP2 for the Treatment of Pancreatic Cancer
新型基于鹅膏蕈碱的抗体药物偶联物靶向TROP2治疗胰腺癌
期刊:
Mol Cancer Ther
影响因子:
5.300
doi:
10.1158/1535-7163.MCT-24-0266
Eleni Papacharisi ,Alexandra C Braun ,Marija Vranic ,Andreas M Pahl ,Torsten Hechler
1
2
3
4
5
6
10